Cibus (CBUS) Assets (2016 - 2026)
Cibus (CBUS) posted Assets of $305.0 million for Q4 2025, down 7.62% sequentially from $330.2 million in Q3 2025, and down 12.86% YoY from $350.1 million in Q4 2024.
Cibus (CBUS) Assets (2016 - 2026) Analysis & Trends
Cibus has reported Assets for 10 years, with the latest figure at $305.0 million in Q4 2025.
- Quarterly Assets fell 12.86% year-over-year to $305.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $305.0 million (down 12.86% YoY) and the FY2025 annual result came in at $305.0 million, down 12.86% from the prior year.
- Assets slipped to $305.0 million in Q4 2025 per CBUS's latest filing, from $330.2 million in the prior quarter.
- Over five years, Assets peaked at $814.3 million in Q2 2023 and troughed at $20.3 million in Q1 2023.
- A 5-year average of $279.6 million and a median of $317.6 million in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2024: Assets jumped 2881.93% in 2023, then plunged 53.8% in 2024.
- Over 5 years, Assets stood at $37.2 million in 2021, then tumbled by 39.72% to $22.4 million in 2022, then jumped by 2328.13% to $544.4 million in 2023, then plunged by 35.7% to $350.1 million in 2024, then retreated by 12.86% to $305.0 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $305.0 million, $330.2 million, and $346.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | 313.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 313.45 Mn |
| Dec 31, 2025 | 305.05 Mn |
| Sep 30, 2025 | 330.23 Mn |
| Jun 30, 2025 | 346.20 Mn |
| Mar 31, 2025 | 335.05 Mn |
| Dec 31, 2024 | 350.07 Mn |
| Sep 30, 2024 | 367.87 Mn |
| Jun 30, 2024 | 553.38 Mn |
| Mar 31, 2024 | 533.03 Mn |
| Dec 31, 2023 | 544.41 Mn |
| Sep 30, 2023 | 796.24 Mn |
| Jun 30, 2023 | 814.27 Mn |
| Mar 31, 2023 | 20.29 Mn |
| Dec 31, 2022 | 22.42 Mn |
| Sep 30, 2022 | 26.70 Mn |
| Jun 30, 2022 | 32.02 Mn |
| Mar 31, 2022 | 38.35 Mn |
| Dec 31, 2021 | 37.19 Mn |
| Sep 30, 2021 | 39.52 Mn |
| Jun 30, 2021 | 47.78 Mn |